The following interactive courses are available for P.A.C.E. credit. In order to receive your P.A.C.E. certificate, you must:
- Complete the course material.
- Take and pass a final exam. If you do not pass the exam, you must retake the course to attempt the exam again.
- Complete the online evaluation.
New York Blood Center Enterprises is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program.
(eLearning courses are best viewed using Chrome as a browser.)
New eLearning Course Available!
How to Interpret RH Genotyping Reports
Author: Lynsi Rahorst, MHPE, MLS(ASCP)SBBCM
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Objectives:
- Describe different assays that are used in RH genotyping.
- Identify notations for nucleotide changes in the gene, amino acid changes in the protein, and RH alleles detected on a genotype report.
- Discuss predicted phenotypes associated with RH genotyping results.
Tour of a Blood Center
Author: Kay Stephens, MLS(ASCP)SH
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Basic
Objectives:
- Explain the steps in the donation process for whole blood, apheresis red cells, and apheresis platelets.
- Describe the manufacturing, testing, lot release, and labeling processes for blood components.
- Discuss the role of the following blood center departments: Immunohematology Reference Laboratory, Genomics Laboratory, Distribution (Hospital Services), and Quality Assurance.
Other eLearning Courses Available
Adverse Transfusion Event Case Studies: Part 1, Pulmonary Transfusion Reactions
Author: Nancy Van Buren, MD & Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Objectives:
- Discuss the CBC National Healthcare Safety Network (NHSN) criteria for classifying adverse transfusion events.
- Describe the NHSN case definitions of TRALI, TACO and TAD.
- Evaluate the information presented in the case studies to identify the type of pulmonary adverse transfusion event and apply the appropriate CBC NHSN definition criteria.
Adverse Transfusion Event Case Studies: Part 2, Non-Pulmonary Transfusion Reactions
Author: Nancy Van Buren, MD & Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Objectives:
- Discuss the CDC National Healthcare Safety Network (NHSN) criteria for classifying adverse transfusion events.
- Describe the signs and symptoms of adverse transfusion events presented in case studies.
- Evaluate the information presented in the case studies to identify the type of adverse transfusion event and apply the appropriate CDC NHSN case definition criteria.
Autoimmune Hemolytic Anemia
Author: Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Course Objectives:
- Identify the clinical presentations, causes, and subtypes of autoimmune hemolytic anemia.
- Describe the role of the Direct Antiglobulin Test in the serologic evaluation of autoimmune hemolytic anemia.
- Discuss treatment and transfusion management.
Chronic Transfusion Therapy Program: Focus on Sickle Cell Disease
Author: Nancy Van Buren, MD & Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Course Objectives:
- Explain the etiology of sickle cell disease and discuss the transfusion options and transfusion complications in this population.
- Identify the American Society of Hematology 2020 guidelines for transfusion support for sickle cell disease.
- Discuss the role of genotyping and antigen-matched blood for sickle cell patients in a chronic transfusion therapy program.
Common Blood Groups
Author: Lynsi Rahorst, MHPE, MLS(ASCP)SBBCM & Kay Stephens, MT(ASCP)SH
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Objectives:
- Define characteristics of common blood group antigens and antibodies.
- Determine the clinical significance of antibodies to common blood group antigens.
- Select appropriate units for transfusion in case scenarios.
Rh Antibodies as a Result of Altered Rh Epitopes on Transfused Red Blood Cells
Author: Megan Dupont, MLS(ASCP)CMSBBCM
P.A.C.E. Contact Hours: 1.0
Level of Instruction: Intermediate
Objectives:
- Discuss the strategies to reduce alloimmunization in chronically transfused patients.
- Define RH variant alleles and describe how variants may impact patients.
- Describe the investigation of a patient in which Rh antibody was produced despite selection of prophylactic matched red cells
Update on Donor Gender Identity and Individualized Risk-based Assessment
Author: Nancy Van Buren, MD & Jed Gorlin, MD, MBA
P.A.C.E. Contact Hours: 0.5
Level of Instruction: Intermediate
Course Objectives:
- Identify the reasons for the donor deferral criterion related to men who have sex with men (MSM) and women who have sex with MSM and describe how the ADVANCE study will inform the FDA’s decision to move towards individualized risk assessment of donors which fosters inclusivity and respect.
- Explain why pre-exposure prophylaxis (PrEP) drugs impact donor deferral.
- Discuss donor eligibility issues for gender non-conforming donors and describe Innovative Blood Resources approach to overcoming these challenges.